These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 9383016

  • 21. Low-dose 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine causes inflammatory activation of astrocytes in nuclear factor-κB reporter mice prior to loss of dopaminergic neurons.
    Miller JA, Trout BR, Sullivan KA, Bialecki RA, Roberts RA, Tjalkens RB.
    J Neurosci Res; 2011 Mar; 89(3):406-17. PubMed ID: 21259327
    [Abstract] [Full Text] [Related]

  • 22. Injury and strain-dependent dopaminergic neuronal degeneration in the substantia nigra of mice after axotomy or MPTP.
    Liu L, Hsu SS, Kalia SK, Lozano AM.
    Brain Res; 2003 Dec 24; 994(2):243-52. PubMed ID: 14642650
    [Abstract] [Full Text] [Related]

  • 23. Response to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) differs in mouse strains and reveals a divergence in JNK signaling and COX-2 induction prior to loss of neurons in the substantia nigra pars compacta.
    Boyd JD, Jang H, Shepherd KR, Faherty C, Slack S, Jiao Y, Smeyne RJ.
    Brain Res; 2007 Oct 17; 1175():107-16. PubMed ID: 17884023
    [Abstract] [Full Text] [Related]

  • 24. Neuroprotection of midbrain dopaminergic cells in MPTP-treated mice after near-infrared light treatment.
    Shaw VE, Spana S, Ashkan K, Benabid AL, Stone J, Baker GE, Mitrofanis J.
    J Comp Neurol; 2010 Jan 01; 518(1):25-40. PubMed ID: 19882716
    [Abstract] [Full Text] [Related]

  • 25. JNK inhibitor protects dopaminergic neurons by reducing COX-2 expression in the MPTP mouse model of subacute Parkinson's disease.
    Wang Y, Zhang Y, Wei Z, Li H, Zhou H, Zhang Z, Zhang Z.
    J Neurol Sci; 2009 Oct 15; 285(1-2):172-7. PubMed ID: 19604516
    [Abstract] [Full Text] [Related]

  • 26. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure fails to produce delayed degeneration of substantia nigra neurons in monkeys.
    Garrido-Gil P, Belzunegui S, San Sebastián W, Izal-Azcárate A, López B, Marcilla I, Luquin MR.
    J Neurosci Res; 2009 Feb 15; 87(2):586-97. PubMed ID: 18798285
    [Abstract] [Full Text] [Related]

  • 27. The mouse MPTP model: gene expression changes in dopaminergic neurons.
    Kühn K, Wellen J, Link N, Maskri L, Lübbert H, Stichel CC.
    Eur J Neurosci; 2003 Jan 15; 17(1):1-12. PubMed ID: 12534964
    [Abstract] [Full Text] [Related]

  • 28. Expression of S-100 protein is related to neuronal damage in MPTP-treated mice.
    Muramatsu Y, Kurosaki R, Watanabe H, Michimata M, Matsubara M, Imai Y, Araki T.
    Glia; 2003 May 15; 42(3):307-13. PubMed ID: 12673835
    [Abstract] [Full Text] [Related]

  • 29. Neuroprotective effect of silymarin in a MPTP mouse model of Parkinson's disease.
    Pérez-H J, Carrillo-S C, García E, Ruiz-Mar G, Pérez-Tamayo R, Chavarría A.
    Toxicology; 2014 May 07; 319():38-43. PubMed ID: 24607817
    [Abstract] [Full Text] [Related]

  • 30. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L, Garris BL, Garris DR, Lau YS.
    Neuroscience; 2006 Jun 19; 140(1):67-76. PubMed ID: 16533572
    [Abstract] [Full Text] [Related]

  • 31. Differential interactive effects of gliotoxin and MPTP in the substantia nigra and the locus coeruleus in BALB/c mice.
    Chang FW, Wang SD, Lu KT, Lee EH.
    Brain Res Bull; 1993 Jun 19; 31(3-4):253-66. PubMed ID: 7683960
    [Abstract] [Full Text] [Related]

  • 32. Pharmacokinetic, neurochemical, stereological and neuropathological studies on the potential effects of paraquat in the substantia nigra pars compacta and striatum of male C57BL/6J mice.
    Breckenridge CB, Sturgess NC, Butt M, Wolf JC, Zadory D, Beck M, Mathews JM, Tisdel MO, Minnema D, Travis KZ, Cook AR, Botham PA, Smith LL.
    Neurotoxicology; 2013 Jul 19; 37():1-14. PubMed ID: 23523781
    [Abstract] [Full Text] [Related]

  • 33. Single low doses of MPTP decrease tyrosine hydroxylase expression in the absence of overt neuron loss.
    Alam G, Edler M, Burchfield S, Richardson JR.
    Neurotoxicology; 2017 May 19; 60():99-106. PubMed ID: 28377118
    [Abstract] [Full Text] [Related]

  • 34. EGb761 protects against nigrostriatal dopaminergic neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice: role of oxidative stress.
    Rojas P, Serrano-García N, Mares-Sámano JJ, Medina-Campos ON, Pedraza-Chaverri J, Ogren SO.
    Eur J Neurosci; 2008 Jul 19; 28(1):41-50. PubMed ID: 18662333
    [Abstract] [Full Text] [Related]

  • 35. [Protective effects of Cistanche total glycosides on dopaminergic neuron in substantia nigra of model mice of Parkinson's disease].
    Li WW, Yang R, Cai DF.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2008 Mar 19; 28(3):248-51. PubMed ID: 18476428
    [Abstract] [Full Text] [Related]

  • 36. Neuroprotective effects of pramipexole in young and aged MPTP-treated mice.
    Anderson DW, Neavin T, Smith JA, Schneider JS.
    Brain Res; 2001 Jun 29; 905(1-2):44-53. PubMed ID: 11423078
    [Abstract] [Full Text] [Related]

  • 37. Elevation of neuronal MAO-B activity in a transgenic mouse model does not increase sensitivity to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Andersen JK, Frim DM, Isacson O, Beal MF, Breakefield XO.
    Brain Res; 1994 Sep 05; 656(1):108-14. PubMed ID: 7804823
    [Abstract] [Full Text] [Related]

  • 38. MPTP-treated mice: long-lasting loss of nigral TH-ir neurons but not paradoxical sleep alterations.
    Laloux C, Derambure P, Kreisler A, Houdayer E, Bruezière S, Bordet R, Destée A, Monaca C.
    Exp Brain Res; 2008 Apr 05; 186(4):635-42. PubMed ID: 18224307
    [Abstract] [Full Text] [Related]

  • 39. Oestrogens prevent loss of dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) in substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice.
    Jourdain S, Morissette M, Morin N, Di Paolo T.
    J Neuroendocrinol; 2005 Aug 05; 17(8):509-17. PubMed ID: 16011487
    [Abstract] [Full Text] [Related]

  • 40. Heat shock protein 70 kDa over-expression and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced nigrostriatal degeneration in mice.
    Gao L, Díaz-Martín J, Dillmann WH, López-Barneo J.
    Neuroscience; 2011 Oct 13; 193():323-9. PubMed ID: 21782904
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.